American Elements Logo and U.S. Registered Trademark
Yttrium Barium Copper Oxide
YBa2Cu3Ox, X ~ 6.7
Product
Product Code
Order or Specifications
99% Yttrium Barium Copper Oxide
YBA-CUO-02
Contact American Elements
99.5% Yttrium Barium Copper Oxide
YBA-CUO-025
Contact American Elements
99.9% Yttrium Barium Copper Oxide
YBA-CUO-03
Contact American Elements
99.95% Yttrium Barium Copper Oxide
YBA-CUO-035
Contact American Elements
99.99% Yttrium Barium Copper Oxide
YBA-CUO-04
Contact American Elements
99.999% Yttrium Barium Copper Oxide
YBA-CUO-05
Contact American Elements
Yttrium Barium Copper Oxide is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Additional technical, research and safety (MSDS) information is available as is a Reference Calculator for converting relevant units of measurement.

Yttrium is a Block D, Group 3, Period 5 element. The electronic configuration is [Kr] 4d1 5s2. In its elemental form yttrium's CAS number is 7440-65-5. The yttrium atom has a radius of 177.6.pm and it's Van der Waals radius is 200.pm. Yttrium has the highest thermo-dynamic affinity for oxygen of any element. This characteristic is the basis for many of its applications. While not part of the rare earth series, it resembles the heavy rare earths which are sometimes referred to as the “yttrics” for this reason. Another unique characteristic derives from its ability to form crystals with useful properties. Yttrium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Some of the many applications of yttrium include in ceramics for crucibles for molten reactive metals, in florescent lighting phosphors, computer displays and automotive fuel consumption sensors.Yttria stabilized zirconium oxide are used in high temperature applications, such as in thermal plasma sprays to protect aerospace high temperature surfaces and as an electrolyte in solid oxide fuel cells.

Barium is a Block S, Group 2, Period 6 element. The electronic configuration is [Xe] 6s2. In its elemental form barium's CAS number is 7440-39-3. The barium atom has a radius of 217.4.pm and it's Van der Waals radius is 200.pm. Barium is a member of the alkaline-earth metals. It has technical applications in glass, electronics and medicine. It is also used in paints and colorants. Electronic coatings based on barium titanate are essential to cell phones and other microelectronics. It has long been used in medical diagnostic techniques because it makes a good x-ray contrast medium. Barium is a dopant in various fluorescent lamp coating formulas. Barium information, including Technical Data, Safety Data and its high purity properties , research , applications and other useful facts are discussed here. Scientific facts such as the atomic structure, ionization energy , abundance on Earth , conductivity and thermal properties are included.

Copper is a Block D, Group 11, Period 4 element. The electronic configuration is [Ar] 3d10 4s1. In its elemental form copper's CAS number is 7440-50-8. The copper atom has a radius of 127.8 .pm and it's Van der Waals radius is 140.pm. Due to its high electrical conductivity, large amounts of copper are used by the electrical industry for wire. Of all pure metals, only silver has a higher electrical conductivity. Copper is also resistant to corrosion caused by moisture, making it a widely used material in pipes, coins, and jewelry. Copper is often too soft for its applications, so it is incorporated in numerous alloys. For example, brass is a copper-zinc alloy, and bronze is a copper-tin alloy. Copper sulfate (CuSO 4·H2O), also known as blue vitrol, is the most well-known copper compound. It is used as an agricultural poison, an algicide, and as a pigment for inks. Cuprous chloride (CuCl) is a powder used to absorb carbon dioxide (CO2). Copper cyanide (CuCN) is often used in electroplating applications. Copper is available as metal and compounds with purities from 99% to 99.9999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder.

Formula CAS No. Appearance Molecular Weight
YBa2Cu3Ox, X ~ 6.7 107539-20-8  
PRODUCT CATALOG Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
German   Korean   French   Japanese   Spanish   Chinese (Simplified)   Portuguese   Russian   Chinese (Taiwan)   Italian   Turkish   Polish   Dutch   Czech   Swedish   Hungarian   Danish   Hebrew

Production Catalog Available in 32 Countries
 
Periodic table of the elements science and academic information, elements and advanced materials data, scientific presentations and all pages, designs, concepts, logos, and color schemes herein are the copyrighted proprietary rights and intellectual property of American Elements. American Elements is a U.S. Registered Trademark. © 2001-2009. American Elements. All rights reserved.

 

Recent Research & Development for Yttrium

  • Liver transplantation after radioembolization in a patient with unresectable HCC. Luna LE, Kwo PY, Roberts LR, Mettler TA, Gansen DN, Andrews JC, Wiseman GA, Misra VL. Nat Rev Gastroenterol Hepatol. 2009 Nov;6(11):679-83. PMID: 19881519 [PubMed - in process]

  • Assessment of Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) laser fiber wear and tear grade during visual laser ablation of prostatic adenoma. Rózanski W, Klimek L, Jablonowski Z, Sosnowski M. Photomed Laser Surg. 2009 Oct;27(5):799-805. PMID: 19878030 [PubMed - in process]

  • Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Ann Surg Oncol. 2009 Oct 30. [Epub ahead of print] PMID: 19876691 [PubMed - as supplied by publisher]

  • Hepatic vein tumor thrombus as a risk factor for excessive pulmonary deposition of microspheres during TheraSphere therapy for unresectable hepatocellular carcinoma. Fleming CJ, Andrews JC, Wiseman GA, Gansen DN, Roberts LR. J Vasc Interv Radiol. 2009 Nov;20(11):1460-3. PMID: 19875064 [PubMed - in process]

  • Genotoxic effects of 1064-nm Nd:YAG and 532-nm KTP lasers on fibroblast cell cultures. Senturk N, Bedir A, Bilgici B, Aydin F, Okuyucu A, Ozmen ZC, Turanli AY. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print] PMID: 19874333 [PubMed - as supplied by publisher]

  • Axillary hair removal with 1064-nm Nd:YAG laser increases sweat production. Aydin F, Pancar GS, Senturk N, Bek Y, Yuksel EP, Canturk T, Turanli AY. Clin Exp Dermatol. 2009 Oct 23. [Epub ahead of print] PMID: 19874331 [PubMed - as supplied by publisher]

  • The management of treatment-resistant biliary calculi using percutaneous endourologic techniques. Ray AA, Davies ET, Duvdevani M, Razvi H, Denstedt JD. Can J Surg. 2009 Oct;52(5):407-12. PMID: 19865576 [PubMed - in process]

  • [Liver chemoembolization: an update.] Roche A. Bull Cancer. 2009 Oct 29. [Epub ahead of print] French. PMID: 19864205 [PubMed - as supplied by publisher]

  • Results of intraocular lens implantation with capsular tension ring in subluxated crystalline or cataractous lenses in children. Das P, Ram J, Brar GS, Dogra MR. Indian J Ophthalmol. 2009 Nov-Dec;57(6):431-6. PMID: 19861744 [PubMed - in process]

  • Quantitative PCR Analysis for Bcl-2/IgH in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma. Goff L, Summers K, Iqbal S, Kuhlmann J, Kunz M, Louton T, Hagenbeek A, Morschhauser F, Putz B, Lister A, Rohatiner A. J Clin Oncol. 2009 Oct 26. [Epub ahead of print] PMID: 19858392 [PubMed - as supplied by publisher]

  • Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study. Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R. J Vasc Interv Radiol. 2009 Oct 23. [Epub ahead of print] PMID: 19854068 [PubMed - as supplied by publisher]

  • The Role of Tumor Vascularity in Predicting Survival after Yttrium-90 Radioembolization for Liver Metastases. Sato KT, Omary RA, Takehana C, Ibrahim S, Lewandowski RJ, Ryu RK, Salem R. J Vasc Interv Radiol. 2009 Oct 19. [Epub ahead of print] PMID: 19846320 [PubMed - as supplied by publisher]

  • Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver Tumors. Bilbao JI, Garrastachu P, Herráiz MJ, Rodríguez M, Ińarrairaegui M, Rodríguez J, Hernández C, de la Cuesta AM, Arbizu J, Sangro B. Cardiovasc Intervent Radiol. 2009 Oct 20. [Epub ahead of print] PMID: 19841973 [PubMed - as supplied by publisher]

  • Radioimmunotherapy for stem cell transplantation in non-Hodgkin's lymphoma: in pursuit of a complete response. Gisselbrecht C, Vose J, Nademanee A, Gianni AM, Nagler A. Oncologist. 2009;14 Suppl 2:41-51. PMID: 19819923 [PubMed - in process]

  • Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence. Morschhauser F, Dreyling M, Rohatiner A, Hagemeister F, Bischof Delaloye A. Oncologist. 2009;14 Suppl 2:17-29. PMID: 19819921 [PubMed - in process]

  • Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma. Gregory SA, Hohloch K, Gisselbrecht C, Tobinai K, Dreyling M. Oncologist. 2009;14 Suppl 2:4-16. PMID: 19819920 [PubMed - in process]

  • Imaging in targeted delivery of therapy to cancer. Dancey G, Begent RH, Meyer T. Target Oncol. 2009 Oct 8. [Epub ahead of print] PMID: 19838639 [PubMed - as supplied by publisher]

  • Polymerization of Enantiopure Monomers Using Syndiospecific Catalysts: A New Approach To Sequence Control in Polymer Synthesis. Kramer JW, Treitler DS, Dunn EW, Castro PM, Roisnel T, Thomas CM, Coates GW. J Am Chem Soc. 2009 Oct 16. [Epub ahead of print] PMID: 19835375 [PubMed - as supplied by publisher]

  • [Minimally invasive tumor ablation in the liver] Wybranski C, Mohnike K, Ricke J. Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Oct;44(10):670-7; quiz 679. Epub 2009 Oct 15. German. PMID: 19834832 [PubMed - in process]

  • Intraarticular adalimumab in a patient with pigmented villonodular synovitis. Kobak S. Rheumatol Int. 2009 Oct 10. [Epub ahead of print] PMID: 19820943 [PubMed - as supplied by publisher]

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com